GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Current Assets (2009 - 2026)

Updated

Gsk (GSK) posted Current Assets of $23.56 billion for the quarter ended Jun 30, 2026, down 0.1% from $23.58 billion a year earlier and down 1.6% from the prior quarter.

Analysis

Gsk (GSK) Current Assets (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk's Current Assets came in at $23.09 billion, up 6.3% from the prior year.

  • Annual Current Assets shows a five-year compound annual growth rate of -2.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, Gsk's Current Assets was $21.73 billion in the year ended Dec 31, 2024 (-6.3%), $23.19 billion in the year ended Dec 31, 2023 (-9.8%), $25.7 billion in the year ended Dec 31, 2022 (unchanged) and $25.69 billion in the year ended Dec 31, 2021 (-1.2%).
  • Quarterly Current Assets has run from a low of $20.53 billion in the quarter ended Mar 31, 2022 to a high of $68.24 billion in the quarter ended Jun 30, 2022 over five years.
  • On a year-over-year basis, Current Assets increased in five of the last eight quarters, with growth averaging 1.6%.
  • The strongest year-over-year quarter for Current Assets in the past five years was the quarter ended Jun 30, 2022, with growth of 177.9%; the weakest was the quarter ended Jun 30, 2023, with a decline of 64.5%.
  • According to Business Quant data, Current Assets for the three prior quarters was $23.94 billion (quarter ended Mar 31, 2026), $23.29 billion (quarter ended Dec 31, 2025) and $24.08 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 59.77 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 33.67 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 27.97 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 13.95 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 41.36 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn 23.56 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.56 Bn
Mar 31, 2026 23.94 Bn
Dec 31, 2025 23.29 Bn
Sep 30, 2025 24.08 Bn
Jun 30, 2025 23.58 Bn
Mar 31, 2025 22.78 Bn
Dec 31, 2024 21.82 Bn
Sep 30, 2024 22.48 Bn
Jun 30, 2024 21.16 Bn
Mar 31, 2024 21.82 Bn
Dec 31, 2023 23.14 Bn
Sep 30, 2023 26.90 Bn
Jun 30, 2023 24.21 Bn
Mar 31, 2023 23.97 Bn
Dec 31, 2022 24.36 Bn
Sep 30, 2022 23.86 Bn
Jun 30, 2022 68.24 Bn
Mar 31, 2022 20.53 Bn
Dec 31, 2021 25.17 Bn
Sep 30, 2021 25.16 Bn
API Access

Gsk Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=GSK&period=max&api_key=YOUR_API_KEY